BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28128455)

  • 21. Genetic, Cellular and Clinical Features of ICF Syndrome: a French National Survey.
    Sterlin D; Velasco G; Moshous D; Touzot F; Mahlaoui N; Fischer A; Suarez F; Francastel C; Picard C
    J Clin Immunol; 2016 Feb; 36(2):149-59. PubMed ID: 26851945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ZBTB24 is a transcriptional regulator that coordinates with DNMT3B to control DNA methylation.
    Thompson JJ; Kaur R; Sosa CP; Lee JH; Kashiwagi K; Zhou D; Robertson KD
    Nucleic Acids Res; 2018 Nov; 46(19):10034-10051. PubMed ID: 30085123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of ZBTB24 protein domains and motifs for heterochromatin localization and transcriptional activation.
    Aktar S; Sasaki H; Unoki M
    Genes Cells; 2019 Nov; 24(11):746-755. PubMed ID: 31561277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HELLS and CDCA7 comprise a bipartite nucleosome remodeling complex defective in ICF syndrome.
    Jenness C; Giunta S; Müller MM; Kimura H; Muir TW; Funabiki H
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):E876-E885. PubMed ID: 29339483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDCA7 and HELLS suppress DNA:RNA hybrid-associated DNA damage at pericentromeric repeats.
    Unoki M; Sharif J; Saito Y; Velasco G; Francastel C; Koseki H; Sasaki H
    Sci Rep; 2020 Oct; 10(1):17865. PubMed ID: 33082427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis of specific DNA binding by the transcription factor ZBTB24.
    Ren R; Hardikar S; Horton JR; Lu Y; Zeng Y; Singh AK; Lin K; Coletta LD; Shen J; Lin Kong CS; Hashimoto H; Zhang X; Chen T; Cheng X
    Nucleic Acids Res; 2019 Sep; 47(16):8388-8398. PubMed ID: 31226215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells.
    Tao Q; Huang H; Geiman TM; Lim CY; Fu L; Qiu GH; Robertson KD
    Hum Mol Genet; 2002 Sep; 11(18):2091-102. PubMed ID: 12189161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome.
    Hansen RS; Wijmenga C; Luo P; Stanek AM; Canfield TK; Weemaes CM; Gartler SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14412-7. PubMed ID: 10588719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline genes hypomethylation and expression define a molecular signature in peripheral blood of ICF patients: implications for diagnosis and etiology.
    Velasco G; Walton EL; Sterlin D; Hédouin S; Nitta H; Ito Y; Fouyssac F; Mégarbané A; Sasaki H; Picard C; Francastel C
    Orphanet J Rare Dis; 2014 Apr; 9():56. PubMed ID: 24742017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNMT3B deficiency presenting as severe combined immune deficiency: A case report.
    Mehawej C; Khalife H; Hanna-Wakim R; Dbaibo G; Farra C
    Clin Immunol; 2020 Jun; 215():108453. PubMed ID: 32360517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, Immunologic and Molecular Spectrum of Patients with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome: A Systematic Review.
    Kiaee F; Zaki-Dizaji M; Hafezi N; Almasi-Hashiani A; Hamedifar H; Sabzevari A; Shirkani A; Zian Z; Jadidi-Niaragh F; Aghamahdi F; Goudarzvand M; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
    Endocr Metab Immune Disord Drug Targets; 2021; 21(4):664-672. PubMed ID: 32533820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and genetic manifestations of immunodeficiency, centromeric instability, and facial anomalies syndrome: a case report and literature review].
    Hu SC; Wang YB; Sun Q; Liu XR; Sun LL; Cui GM
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):55-59. PubMed ID: 30630233
    [No Abstract]   [Full Text] [Related]  

  • 33. A functional assay to classify ZBTB24 missense variants of unknown significance.
    Wu H; Vonk KKD; van der Maarel SM; Santen GWE; Daxinger L
    Hum Mutat; 2019 Aug; 40(8):1077-1083. PubMed ID: 31066130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunodeficiency, centromeric instability, facial anomalies (ICF) syndrome, due to ZBTB24 mutations, presenting with large cerebral cyst.
    Cerbone M; Wang J; Van der Maarel SM; D'Amico A; D'Agostino A; Romano A; Brunetti-Pierri N
    Am J Med Genet A; 2012 Aug; 158A(8):2043-6. PubMed ID: 22786748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Clinical and Immunological Alterations Associated with ICF Syndrome.
    Bilgic Eltan S; Nain E; Catak MC; Ezen E; Sefer AP; Karimi N; Kiykim A; Kolukisa B; Baser D; Bulutoglu A; Kasap N; Yorgun Altunbas M; Yalcin Gungoren E; Kendir Demirkol Y; Kutlug S; Hancioglu G; Dilek F; Yildiran A; Ozen A; Karakoc-Aydiner E; Erman B; Baris S
    J Clin Immunol; 2023 Dec; 44(1):26. PubMed ID: 38129713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF).
    Ehrlich M; Jackson K; Weemaes C
    Orphanet J Rare Dis; 2006 Mar; 1():2. PubMed ID: 16722602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel
    Aminorroaya A; Rayzan E; Shahkarami S; Seyedpour S; Zoghi S; Aryan Z; Somekh I; Rohlfs M; Klein C; Esmaeilzadeh H; Rezaei N
    Endocr Metab Immune Disord Drug Targets; 2023; 23(3):410-415. PubMed ID: 35996251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome.
    Helfricht A; Thijssen PE; Rother MB; Shah RG; Du L; Takada S; Rogier M; Moritz J; IJspeert H; Stoepker C; van Ostaijen-Ten Dam MM; Heyer V; Luijsterburg MS; de Groot A; Jak R; Grootaers G; Wang J; Rao P; Vertegaal ACO; van Tol MJD; Pan-Hammarström Q; Reina-San-Martin B; Shah GM; van der Burg M; van der Maarel SM; van Attikum H
    J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32865561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation in ICF syndrome: evidence for genetic heterogeneity.
    Wijmenga C; Hansen RS; Gimelli G; Björck EJ; Davies EG; Valentine D; Belohradsky BH; van Dongen JJ; Smeets DF; van den Heuvel LP; Luyten JA; Strengman E; Weemaes C; Pearson PL
    Hum Mutat; 2000 Dec; 16(6):509-17. PubMed ID: 11102980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease.
    Ehrlich M
    Clin Immunol; 2003 Oct; 109(1):17-28. PubMed ID: 14585272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.